Transoral robotkirurgi til behandling af hoved-hals-kræft

Translated title of the contribution: Transoral robotic surgery for head and neck cancer

Hani Ibrahim Channir, Asher Lou Isenberg, Niclas Rubek, Anne Fog Lomholt, Susanne Irene Scott, Jesper Flitenborg Tvedskov, Birgitte Wittenborg Charabi, Christian von Buchwald


Oropharyngeal squamous cell carcinoma (OPSCC) induced by human papillomavirus (HPV) is highly prevalent in the western part of the world. Patients with HPV-induced OPSCC are often younger and have a much better prognosis than patients with HPV-negative OPSCC. The newly introduced transoral robotic surgery offers the ability to perform en bloc tumour resection with good margin control. It may be an alternative to the traditional radiation therapy for early-stage OPSCC. A Danish randomised clinical trial is now aiming at comparing these two treatments with a focus on long-term functional outcomes.

Translated title of the contributionTransoral robotic surgery for head and neck cancer
Original languageDanish
JournalUgeskrift for Laeger
Issue number47
Pages (from-to)V05180341
Publication statusPublished - 19 Nov 2018


Dive into the research topics of 'Transoral robotic surgery for head and neck cancer'. Together they form a unique fingerprint.

Cite this